The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Human Cannabinoid Pharmacokinetics
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both THC and CBD are predominantly metabolized, by the liver, through the action of the cytochrome P450 system.104,105”
From Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions (2024) · cites this paper as [104]
Citations
Cites
Pharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,514
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Russo, E. B., & Guy, G. W. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 608
Constituents of Cannabis sativa L. XVII. A review of the natural constituents
Turner, C. E., Elsohly, M. A., & Boeren, E. G. (1980) · Journal of Natural Products · doi:10.1021/np50008a001 · Cited by 599
Cannabis: pharmacology and toxicology in animals and humans
Adams, I. B., & Martin, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 576
Cannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J., Brown, P., Pertwee, R., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 546
Flagged first, then by citations
Research works printed but not linked: 26
- Agurell S., 1971, Acta Pharm. Suecica, 8, 391
- Agurell S., 1986, Pharmacol. Rev., 38, 21
- Azorlosa J. L., 1992, J. Pharmacol. Exper. Ther., 261, 114
- Perez‐Reyes M., 1990, NIDA Res. Monograph, 99, 42
- Harder S., 1997, Int. J. Clin. Pharmacol. Ther., 35, 155
- Ohlsson A., 1981, NIDA Res. Monograph, 34, 250
- Meier H. J., 1997, Schweiz. Med. Wochenschr., 127, 214
- Brenneisen R., 1996, Int. J. Clin. Pharmacol. Ther., 34, 446
- Vinciguerra V., 1988, N. Y. State J. Med., 88, 525
- McArdle K., 2001, Toxicology, 168, 133
- Garrett E. R., 1978, Adv. Biosci., 22, 105
- Hunt C. A., 1980, J. Pharmacol. Exper. Ther., 215, 35
- Lee C. C., 1985, NIDA Res. Monograph, 60, 110
- Martin B. R., 1977, Res. Commun. Chem. Pathol. Pharmacol., 17, 457
- Ben‐Zvi Z., 1974, Res. Commun. Chem. Pathol. Pharmacol., 8, 223
- Harvey D. J., 1986, Rev. Biochem. Toxicol., 6, 221
- Bornheim L. M., 1992, Drug Metab. Dispos., 20, 241
- Halldin M. M., 1982, Drug Metab. Dispos., 10, 297
- Chiang C. N., 1987, NIDA Res. Monograph
- Bloom A. S., 1982, J. Pharmacol. Exper. Ther., 221, 97
- Green M. D., 1997, Drug Metab. Dispos., 25, 1389
- Mura P., 1999, Acta Clin. Belg., 1, 35
- Soares J. R., 1982, NIDA Res. Monograph, 42, 44
- Hawks R. L., 1982, NIDA Res. Monograph, 42, 125
- Huestis M. A., 1992, Am. Acad. Forensic Sci. Annual Meeting, 190
- Balabanova S., 1989, Beitr. Gerichtl. Med., 48, 45
Cited by
Sorted by citations
Items 601–700 of 1,000
Aviram, J., Glezerman, M., Hayam, E., Belobrov, R., Procaccia, S., Meiri, D., & Eisenberg, E. (2023) · Pharmaceuticals · doi:10.3390/ph16101426 · Cited by 11
Pressman, P., Hayes, A., Hoeng, J., Latino, D., Mazurov, A., Schlage, W., & Rana, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061540 · Cited by 11
Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo
Chu, P.-C., Liao, M.-H., Liu, M.-G., Li, C.-Z., & Lai, P. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s455032 · Cited by 11
Development and validation of a mouse model of contemporary cannabis smoke exposure
Fantauzzi, M. F., Cass, S. P., McGrath, J. J. C., Thayaparan, D., Wang, P., Stämpfli, M. R., & Hirota, J. A. (2021) · ERJ Open Research · doi:10.1183/23120541.00107-2021 · Cited by 11
Slotkin, T. A., Levin, E. D., & Seidler, F. J. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab117 · Cited by 11
Lajoie, C., Doyen, A., Feutry, P., Gagnon, D., & Brisson, G. J. (2022) · Food & Function · doi:10.1039/d2fo01591a · Cited by 11
Treyer, A., Reinhardt, J. K., Eigenmann, D. E., Oufir, M., & Hamburger, M. O. (2023) · Medical Cannabis and Cannabinoids · doi:10.1159/000528465 · Cited by 11
Schwark, W. S., & Wakshlag, J. J. (2023) · American Journal of Veterinary Research · doi:10.2460/ajvr.23.02.0031 · Cited by 11
Routes of Administration, Pharmacokinetics and Safety of Medicinal Cannabis
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_11 · Cited by 11
Clinical Approaches to Cannabis
Slawek, D. E., Curtis, S. A., Arnsten, J. H., & Cunningham, C. O. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.004 · Cited by 11
Barnard, I. L., Onofrychuk, T. J., Sandini, T. M., McElroy, D. L., Zagzoog, A., Roebuck, A. J., Austin-Scott, F. V. L., Laprairie, R. B., & Howland, J. G. (2022) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2022.107624 · Cited by 8
Medical Cannabis in Hand Surgery: A Review of the Current Evidence
Yang, A., Townsend, C. B., & Ilyas, A. M. (2023) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2022.11.008 · Cited by 10
Young‐Wolff, K. C., Green, A., Iturralde, E., Altschuler, A., Does, M. B., Jackson-Morris, M., Adams, S. R., Ansley, D. R., Conway, A., Goler, N. C., et al. (2024) · Journal of Women s Health · doi:10.1089/jwh.2023.0066 · Cited by 10
Hume, C., Baglot, S. L., Javorcikova, L., Lightfoot, S. H. M., Scheufen, J., & Hill, M. N. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01512-8 · Cited by 10
Impact of Dietary Fat and Oral Delivery System on Cannabigerol Pharmacokinetics in Adults
Story, G., Lee, J., Cohen, G., Rani, A., Doherty, J., & Sela, D. A. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0174 · Cited by 10
O’Connell, K. C., Almeida, M. B., Nouwairi, R. L., Costen, E. T., Lawless, N. K., Charette, M. E., Stewart, B. M., Nixdorf, S. L., & Landers, J. P. (2024) · Lab on a Chip · doi:10.1039/d4lc00223g · Cited by 10
Thompson, E. S., Alcorn, J., & Neary, J. P. (2024) · Sports Medicine · doi:10.1007/s40279-024-02094-1 · Cited by 10
Are Cannabis-Based Medicines a Useful Treatment for Neuropathic Pain? A Systematic Review
Almuntashiri, N., Sharazly, B. M. E., & Carter, W. G. (2025) · Biomolecules · doi:10.3390/biom15060816 · Cited by 10
Potential Drug Interactions Between Cannabinoids and Its Derivatives and Oral Anticoagulants
Paduch, M., & Thomason, A. R. (2021) · Hospital Pharmacy · doi:10.1177/0018578720985438 · Cited by 10
The Pharmacology of Cannabinoids
Copas, G., Amazonas, E. D. A., & Brandon, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-68317-7_2 · Cited by 10
Metabolomic Fingerprint of Behavioral Changes in Response to Full-Spectrum Cannabis Extracts
Maayah, Z. H., Raposo, P. J. F., Silver, H. L., Mandal, R., Ellis, L., Alam, A. S., Takahara, S., Ferdaoussi, M., Mathewson, K. E., Eurich, D. T., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.831052 · Cited by 10
High-Potency Cannabis Use in Adolescence
Vargas, G., Shrier, L. A., Chadi, N., & Harris, S. K. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.07.034 · Cited by 10
Zamarripa, C., Novak, M., Weerts, E., Vandrey, R., & Spindle, T. R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.964749 · Cited by 8
Aviram, J., Atzmony, D., Frenklakh, A., Kroll, A., Zaks, I., & Hazekamp, A. (2022) · Journal of Cannabis Research · doi:10.1186/s42238-022-00166-5 · Cited by 10
Anticoagulant drug–drug interactions with cannabinoids: A systematic review
Smythe, M. A., Wu, W. G., & Garwood, C. L. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2881 · Cited by 10
Cannabidiol - Help and hype in targeting mucosal diseases
Moniruzzaman, M., Janjua, T. I., Martin, J. H., Begun, J., & Popat, A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.010 · Cited by 10
Kuzma-Hunt, A. G., Sabry, R., Davis, O. S., Truong, V. B., Khokhar, J. Y., & Favetta, L. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298697 · Cited by 12
Palamar, J. J., Lee, L., & Weitzman, M. L. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1011745 · Cited by 12
Hädener, M., Weinmann, W., van Staveren, D. R., & König, S. (2017) · Bioanalysis · doi:10.4155/bio-2016-0281 · Cited by 10
Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer
Rower, J. E., King, A. D., Wilkins, D. G., Wilkes, J., Yellepeddi, V., Maese, L. D., Lemons, R. S., & Constance, J. E. (2020) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2020.0021 · Cited by 10
Claus, B. B., Specka, M., McAnally, H. B., Scherbaum, N., Schifano, F., & Bonnet, U. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.598150 · Cited by 11
Medicinal uses of Cannabis sp.
de Souza, A. A. F., da Silva, A. F. M., de Abreu, L. R., da Silva, T. F., Greco, G. L. C., Santos, S. D. S., & Gonzaga, R. V. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16930 · Cited by 11
Cannabinoid distribution in fatally-injured pilots’ postmortem fluids and tissues
Cliburn, K. D., Huestis, M. A., Wagner, J. R., & Kemp, P. M. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.111075 · Cited by 10
Self-citationKöck, P., Lang, E., Trulley, V.-N., Dechent, F., Mercer‐Chalmers‐Bender, K., Frei, P., Huber, C. G., & Borgwardt, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.736822 · Cited by 9
Bardhi, K., Coates, S., Chen, G., & Lazarus, P. J. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020243 · Cited by 9
Trif, C., Harpaz, D., Eltzov, E., Parcharoen, Y., Pechyen, C., & Marks, R. S. (2024) · Biosensors · doi:10.3390/bios14030126 · Cited by 9
Khan, M. G., Hussain, S. H. A., Alkhayl, F. F. A., Ahsan, M., & Ridha‐Salman, H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04134-7 · Cited by 10
Medicinal Cannabis – The Green Fairy Phenomenon
Raymond, O., McCarthy, M. J., Baker, J., & Poulsen, H. (2021) · Australian Journal of Chemistry · doi:10.1071/ch21001 · Cited by 9
Affinity Assays for Cannabinoids Detection: Are They Amenable to On-Site Screening?
Puiu, M., & Bala, C. (2022) · Biosensors · doi:10.3390/bios12080608 · Cited by 9
Proença, P., Teixeira, H. M., Martinho, B., Monteiro, C., Franco, J. M., & Corte-Real, F. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad046 · Cited by 9
Barnard, I. L., Onofrychuk, T. J., Toderash, A. D., Patel, V. N., Glass, A. E., Adrian, J. C., Laprairie, R. B., & Howland, J. G. (2023) · eNeuro · doi:10.1523/eneuro.0115-23.2023 · Cited by 10
LC–MS-MS quantification of Δ8-THC, Δ9-THC, THCV isomers and their main metabolites in human plasma
Sempio, C., Campos-Palomino, J., Klawitter, J., Harrison, A., Peters, E. N., MacNair, L., Haghdoost, M., Bonn‐Miller, M. O., Babalonis, S. L., Huestis, M. A., et al. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae048 · Cited by 9
Self-citationThe Development of Cannabinoids as Therapeutic Agents in the United States
Murray, C. H., Gannon, B. M., Winsauer, P. J., Cooper, Z. D., & Delatte, M. S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001121 · Cited by 10
8β-OH-THC and 8β,11-diOH-THC—minor metabolites with major informative value?
Gasse, A., Pfeiffer, H., Köhler, H., & Schürenkamp, J. (2017) · International Journal of Legal Medicine · doi:10.1007/s00414-017-1692-5 · Cited by 9
The estimation of cannabis consumption through wastewater analysis
Bijlsma, L., Burgard, D. A., Béen, F. M., Ort, C., Matias, J., & Yargeau, V. (2020) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2020.04.005 · Cited by 9
Goggin, M. M., & Janis, G. C. (2020) · Clinical Toxicology · doi:10.1080/15563650.2020.1827148 · Cited by 9
Medicinal Cannabis: an overview for health-care providers
Wallach, J. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820007-0.00005-2 · Cited by 9
Assessment of biological matrices for the detection of in utero cannabis exposure
Concheiro, M., Gutierrez, F. M., Ocampo, A., Lendoiro, E., Colmenero, E. G., Concheiro‐Guisán, A., Peñas‐Silva, P., Macías‐Cortiña, M., Cruz, A., López‐Rivadulla, M., et al. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3034 · Cited by 9
Gorziza, R. P., Cox, J., Limberger, R. P., & Arroyo, L. (2021) · Journal of Cannabis Research · doi:10.1186/s42238-021-00088-8 · Cited by 9
Hunt, D. A., Keefe, J., Whitehead, T., & Littlefield, A. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.07.007 · Cited by 9
Ujváry, I., & Grotenhermen, F. (2014) · Cited by 9
Marijuana Addictive Disorders and DSM-5 Substance-Related Disorders
Miller, N. S., Oberbarnscheidt, T., & Gold, M. S. (2017) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s11-013 · Cited by 9
Making “Weedish Fish”: An Exploratory Analysis of Cannabis Recipes on Pinterest
Laestadius, L. I., Guidry, J. P. D., Greskoviak, R., & Adams, J. A. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1638410 · Cited by 9
Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolbox
Lacroix, C., Guilhaumou, R., Micallef, J., & Blin, O. J. (2023) · Therapies · doi:10.1016/j.therap.2023.05.003 · Cited by 8
Suraev, A. S., McCartney, D., Kevin, R. C., Gordon, R., Grunstein, R. R., Hoyos, C. M., & McGregor, I. S. (2024) · Drug Testing and Analysis · doi:10.1002/dta.3658 · Cited by 8
Chye, D. M., Rodrigues, T. S., Quarto, L. J. G., Young, N., Hamilton, G. W., Burrell, L. M., Teh, A. W., Lim, H. S., & Koshy, A. N. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.05.062 · Cited by 8
The novel cannabinoid CB1 receptor agonist AM11101 increases food intake in female rats
Ogden, S. B., Malamas, M. S., Makriyannis, A., & Eckel, L. A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14797 · Cited by 8
Transmucosal delivery of the medical Cannabis oil via a nanoemulsion formulation
d’Angelo, I., Provenzano, R., Florio, E., Lombardi, A., Trama, U., Ungaro, F., Quaglia, F., & Miro, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104004 · Cited by 8
Adolescent exposure to low-dose Δ9-tetrahydrocannabinol depletes the ovarian reserve in female mice
Lim, J., Lee, H.-L., Nguyen, J. K., Shin, J. H., Getze, S., Quach, C., Squire, E., Jung, K., Mahler, S. V., Mackie, K., et al. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad027 · Cited by 9
Oliveira, I. G. C., Grecco, C. F., de Souza, I. D., & Queiroz, M. E. C. (2024) · Green Analytical Chemistry · doi:10.1016/j.greeac.2024.100161 · Cited by 8
Li, T., Wang, G. S., Brooks‐Russell, A., Tung, G. J., Leslie, L., Rittiphairoj, T., Oberste, J.-P., Yim, T. W., Bero, L. A., & Samet, J. M. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae421 · Cited by 8
Klotter, F., & Studer, A. (2015) · Angewandte Chemie · doi:10.1002/ange.201502595 · Cited by 8
Mardal, M., Annaert, P., Noble, C., Oorts, M., & Línnet, K. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.11.027 · Cited by 8
Zinka, B., Epple, S., Schick, S., Skopp, G., Graw, M., & Mußhoff, F. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2496 · Cited by 8
Dryburgh, L. M., & Martin, J. H. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000698 · Cited by 8
Edalatpour, A., Attaluri, P. K., & Larson, J. D. (2020) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000002838 · Cited by 8
Saulino, P. A., Greenwald, B. D., & Gordon, D. J. (2021) · Brain Injury · doi:10.1080/02699052.2021.1978548 · Cited by 8
Robert, M., Graves, L. E., Allen, V. M., Dama, S., Gabrys, R. L., Tanguay, R. L., Turner, S. D., Green, C. R., & Cook, J. L. (2022) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2022.01.012 · Cited by 8
Aviram, J., Atzmony, D., & Eisenberg, E. (2022) · PAIN Reports · doi:10.1097/pr9.0000000000001011 · Cited by 8
Impact of cannabis‐infused edibles on public safety and regulation
Peralt, A., Ke, P., & Castaneto, M. S. (2022) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15135 · Cited by 8
UHPLC–MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers
Faro, A. F. L., Tini, A., Gottardi, J., Pichini, S., Carlier, J., Giorgetti, R., & Busardò, F. P. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac081 · Cited by 8
Establishment of a point of departure for CBD hepatotoxicity employing human HepaRG spheroids
Li, J., Zagorski, J. W., & Kaminski, N. E. (2023) · Toxicology · doi:10.1016/j.tox.2023.153469 · Cited by 10
Tormey, W. P. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200383 · Cited by 8
Hädener, M., Fabritius, M. M., König, S., Giroud, C., & Weinmann, W. (2016) · Drug Testing and Analysis · doi:10.1002/dta.2114 · Cited by 8
El-Safty, I., Eltamany, E. H. M., Shouman, A., El-Gamel, O. A., Nada, A. S., & Ali, W. (2018) · African Health Sciences · doi:10.4314/ahs.v18i3.35 · Cited by 8
Cannabidiol primer for healthcare professionals
Cather, J. C., & Cather, J. C. (2020) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2020.1775437 · Cited by 10
Järbe, T. U. C., & Raghav, J. G. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_16 · Cited by 8
Cannabis for Gastroparesis: Hype or Hope?
McCallum, R. W., & Bashashati, M. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000277 · Cited by 8
Moore, B. F., Mueller, N. T., Perng, W., Sauder, K. A., Hébert, E. T., Hoyt, A. T., Wymore, E. M., Boyle, K. E., Su, E. J., Shapiro, A. L. B., et al. (2024) · Pediatric Obesity · doi:10.1111/ijpo.13187 · Cited by 7
Šoša, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178635 · Cited by 7
Cannabis impacts female fertility as evidenced by an in vitro investigation and a case-control study
Duval, C., Wyse, B. A., Weizman, N. F., Kuznyetsova, I., Madjunkova, S., & Librach, C. L. (2025) · Nature Communications · doi:10.1038/s41467-025-63011-2 · Cited by 7
Canada's THC unit: Applications for the legal cannabis market
Wood, S., Gabrys, R. L., Freeman, T. P., & Hammond, D. G. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104457 · Cited by 7
Controlled release tablet formulation containing natural Δ9-tetrahydrocannabinol
Punyamurthula, N. S., Hingorani, T., Adelli, G. R., Gul, W., ElSohly, M. A., Repka, M. A., & Majumdar, S. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1118490 · Cited by 7
The therapeutic use of cannabinoids: Forensic aspects
Indorato, F., Liberto, A., Ledda, C., Romano, G., & Barbera, N. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2016.03.031 · Cited by 7
CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure
Lambros, A. M., Sagar, K. A., Dahlgren, M. K., Kosereisoglu, D., El-Abboud, C., Smith, R. T., & Gruber, S. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-32671-9 · Cited by 7
Analgesic and Anti-Inflammatory Effects of 1% Topical Cannabidiol Gel in Animal Models
Bunman, S., Muengtaweepongsa, S., Piyayotai, D., Charlermroj, R., Kanjana, K., Kaew-amdee, S., Makornwattana, M., & Kim, S.-H. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0070 · Cited by 7
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist
BURSTEIN, S. H., & Tepper, M. A. (2013) · Pharmacology Research & Perspectives · doi:10.1002/prp2.17 · Cited by 7
Krämer, M., Broecker, S., Diehl, B. W. K., Madea, B., & Heß, C. (2018) · Forensic Science International · doi:10.1016/j.forsciint.2018.11.005 · Cited by 7
Cannabis für medizinische Zwecke und seine ärztliche Verordnung
Kiefer, A., Eckert-Lill, C., Bussick, D., Hörnig, M., & Reimann, H. (2019) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-019-02970-6 · Cited by 7
An Agathokakological Tale of Δ9-THC: Exploration of Possible Biological Targets
Mathew, B., Harilal, S., Musa, A., Kumar, R., Parambi, D. G. T., Jose, J., Uddin, M. S., Shah, M. A., Behl, T., & Unnikrishnan, M. K. (2020) · Current Drug Targets · doi:10.2174/1389450121666201001123515 · Cited by 6
The consequences of chronic cannabis smoking in vulnerable adolescents
Al‐Iede, M., Nunn, K. P., Milne, B., & Fitzgerald, D. A. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.11.001 · Cited by 7
High standards: considerations for the application of the standard THC unit
Arkell, T. R., Hayley, A. C., & Downey, L. A. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00394-1 · Cited by 7
Effects of different methods of cannabis use on cognition and blood THC: A systematic review.
Behzad, D., Patel, S., Besa, R., Chan, A. W. H., Chen, S., Rueda, S., Ruocco, A. C., & Di Ciano, P. (2025) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111399 · Cited by 7
Sobieraj, J., Strzelecka, K., Sobczak, M., & Olędzka, E. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s458907 · Cited by 7
Medical cannabis in Israel: a comprehensive review of trends and regulations, 2011–2025
Aviram, J. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00344-1 · Cited by 6
Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks
Papakyriakopoulou, P., Valsami, G. N., & Ismailos, G. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70430 · Cited by 7
Trojan, V., Landa, L., Hřib, R., Juřica, J., Rychlíčková, J., ZVONICEK, V., Halámková, L., Halámek, J., Demlová, R., Bělašková, S., et al. (2022) · Physiological Research · doi:10.33549/physiolres.934907 · Cited by 6
Is marijuana a foe of male sexuality? Data from a large cohort of men with sexual dysfunction
Barbonetti, A., Rastrelli, G., Sparano, C., Castellini, C., Vignozzi, L., Maggi, M., & Corona, G. (2023) · Andrology · doi:10.1111/andr.13382 · Cited by 6
Can we predict the treatment doses of THC and CBD and does it matter?
Halamish, N., Schleider, L. B., McGuire, S. F., & Novack, V. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.03.028 · Cited by 6
Cannabinoid Use in the Treatment of Laryngeal Dystonia and Vocal Tremor: A Pilot Investigation
Millman, N., van der Woerd, B. D., Sund, L. T., & Johns, M. M. E. (2023) · Journal of Voice · doi:10.1016/j.jvoice.2023.05.006 · Cited by 6
Metadata
- Authors
- Huestis, M. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Huestis, Marilyn A.
- ORCID
- Huestis, Marilyn A.
- Venue
- Chemistry & Biodiversity
- Publisher
- Wiley
- Published
- 2007-08
- Volume
- 4
- Issue
- 8
- Pages
- 1770-1804
- ISSN
- 1612-1872 (ISSN-L)
- 1612-1880
- PMC
- PMC2689518
- OpenAlex
- W2169754532
- Cited by
- 1,102
- References
- 173
- Citations by year
- 2026: 79 · 2025: 97 · 2024: 77 · 2023: 114 · 2022: 109 · 2021: 121 · 2020: 132 · 2019: 117 · 2018: 70 · 2017: 56 · 2016: 42 · 2015: 31 · 2014: 14 · 2013: 13 · 2012: 10
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Chemistry & Biodiversity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (Z01DA000413, Z01DA000415, Z01DA000412)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- cannabinoids, pharmacokinetics, human metabolism, drug absorption, distribution, metabolism, excretion
- MeSH terms
- Cannabinoids, Humans, Sweat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review